Interest of Wicking for Ossicular Surgery and Myringoplasty (MECH-ORL)

July 5, 2022 updated by: University Hospital, Tours

Intérêt du méchage Pour la Chirurgie Ossiculaire et la Myringoplastie : Essai contrôlé randomisé Multicentrique de Non-infériorité

Myringoplasties and ossicular surgery are very common procedures. Following these otological surgeries, most surgeons install a wicking. This intervention consists of placing a wick, absorbable or not, in the external acoustic meatus, after having replaced the tympanomeatal flap.

Study Overview

Status

Recruiting

Detailed Description

Myringoplasties and ossicular surgery are very common procedures. Following these otological surgeries, most surgeons install a wicking. This intervention consists of placing a wick, absorbable or not, in the external acoustic meatus, after having replaced the tympanomeatal flap.

Putting in place a wicking often requires to remove this wicking, feared by the patient. In addition, wicking leads to obstruction of the external acoustic meatus responsible for functional discomfort (feeling of fullness in the ear, pain, significant conductive deafness) which can last from one to several weeks depending on the type of wicking.

Despite these drawbacks, the rationale for wicking has never been established, the choice of wick type is often empirical, and its necessity is sometimes controversial in the literature. Recent studies have studied the absence of wicking as an alternative to overcome its many drawbacks. No prospective, randomized, multicenter study has been performed to show the superiority of wicking in healing following middle ear surgery (myringoplasty, stapedo-vestibular ankylosis, ossiculoplasty) via the duct or the endaural route. The only study with a high level of evidence concerns only endoscopic surgery. This study has the advantage of showing that with comparable audiometric and healing results, the absence of wicking allows a reduced operating time, an earlier reduction in otorrhea and the feeling of blocked ears, and an earlier improvement of hearing. Given this work in the literature, our hypothesis is that tympanic healing is not impaired in the absence of wicking.

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Blois, France, 41000
        • Recruiting
        • Hospital Blois
        • Contact:
      • Brest, France, 29200
        • Active, not recruiting
        • University Hospital Brest
      • Le Mans, France, 72037
        • Recruiting
        • Hospital Le Mans
        • Contact:
      • Nantes, France, 44000
      • Paris, France, 75013
        • Recruiting
        • Hospital La Pitié Salpêtrière-APHP
        • Contact:
      • Tours, France, 37044
        • Recruiting
        • university hospital Tours
        • Contact:
        • Contact:
        • Sub-Investigator:
          • David BAKHOS, MD-PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patient (age 18 = or + ), whose mother tongue is French or who understands French language
  • Ossicular surgery (fitting of a partial or total ossicular prosthesis) or myringoplasty performed endoscopically, from the speculum, from the duct or from the endaural.
  • Tympanic reconstruction by all types of grafts: cartilage, fascia, autologous fat
  • Written consent signed by the participant
  • Affiliation to a social security scheme,

Exclusion Criteria:

  • Pregnant or breastfeeding woman, patient under legal protection, guardianship or curatorship.
  • Need for a retroauricular approach.
  • Need for annulus detachment> 60%
  • Presence of cholesteatoma or middle ear tumor

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: No wicking
Absence of Wicking after intervention
No wicking after surgery
Active Comparator: Control
Wicking after intervention
Absorbable or non-absorbable wicking

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tympanic and external auditory canal healing
Time Frame: Three months after intervention.
Healing of tympanic membrane and external auditory canal, evaluated blindly by 3 experts, on an oto-endoscopy picture.
Three months after intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Audiometric results
Time Frame: Pre-operative, 3 months, 12 months
Audiometric results defined by the pure-tone average on 500, 1000, 2000 and 3000 Hz frequencies.
Pre-operative, 3 months, 12 months
Post-operative satisfaction
Time Frame: Immediate post-operative, day 7-10, day 30, 3 months
Visual Analogic scale (0-10 (min-max))
Immediate post-operative, day 7-10, day 30, 3 months
Post-operative pain
Time Frame: Immediate post operative,day 7-10, day 30, 3 months
Visual Analogic scale (0-10 (min-max))
Immediate post operative,day 7-10, day 30, 3 months
Post-operative quality of life
Time Frame: Day 7-10, day 30, 3 months,12 months
Glasgow Benefit Inventory (-100 (min) to +100 (max))
Day 7-10, day 30, 3 months,12 months
Post-operative stress
Time Frame: Pre-operative, day 7-10, day 30, 3 months, 12 months
Perceived Stress Scale (PSS-10) 10-50 (min-max) Never to often
Pre-operative, day 7-10, day 30, 3 months, 12 months
Operative time
Time Frame: 30-120 minutes
Operative time of the otology surgery, in minutes
30-120 minutes
Complications
Time Frame: At any time of the follow-up,up to 1 year
Questionnaire given to surgeons, allowing description of complications
At any time of the follow-up,up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Charles AUSSEDAT, MD, University hospital of Tours

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 16, 2022

Primary Completion (Anticipated)

May 16, 2025

Study Completion (Anticipated)

May 16, 2026

Study Registration Dates

First Submitted

January 21, 2022

First Submitted That Met QC Criteria

March 1, 2022

First Posted (Actual)

March 8, 2022

Study Record Updates

Last Update Posted (Actual)

July 6, 2022

Last Update Submitted That Met QC Criteria

July 5, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • DR210132-MECH-ORL
  • 2021-A02788-33 (Registry Identifier: Id-RCB-ANSM-France)
  • 221 A15 (Other Identifier: Comité de Protection des Personnes Sud-Méditerranée II)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-Op Complication

Clinical Trials on No wicking

Subscribe